IBDEI1KM ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27884,0)
 ;;=550.90^^162^1789^19
 ;;^UTILITY(U,$J,358.3,27884,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27884,1,4,0)
 ;;=4^550.90
 ;;^UTILITY(U,$J,358.3,27884,1,5,0)
 ;;=5^Hernia, Inguinal, Unilat
 ;;^UTILITY(U,$J,358.3,27884,2)
 ;;=^63302
 ;;^UTILITY(U,$J,358.3,27885,0)
 ;;=302.72^^162^1789^29
 ;;^UTILITY(U,$J,358.3,27885,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27885,1,4,0)
 ;;=4^302.72
 ;;^UTILITY(U,$J,358.3,27885,1,5,0)
 ;;=5^Impotence, Psychosocial
 ;;^UTILITY(U,$J,358.3,27885,2)
 ;;=^100632
 ;;^UTILITY(U,$J,358.3,27886,0)
 ;;=788.30^^162^1789^59
 ;;^UTILITY(U,$J,358.3,27886,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27886,1,4,0)
 ;;=4^788.30
 ;;^UTILITY(U,$J,358.3,27886,1,5,0)
 ;;=5^Urinary Incontinence, Unspec
 ;;^UTILITY(U,$J,358.3,27886,2)
 ;;=^124400
 ;;^UTILITY(U,$J,358.3,27887,0)
 ;;=V13.01^^162^1789^20
 ;;^UTILITY(U,$J,358.3,27887,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27887,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,27887,1,5,0)
 ;;=5^Hx Of Kidney Stone
 ;;^UTILITY(U,$J,358.3,27887,2)
 ;;=^303403
 ;;^UTILITY(U,$J,358.3,27888,0)
 ;;=302.71^^162^1789^32
 ;;^UTILITY(U,$J,358.3,27888,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27888,1,4,0)
 ;;=4^302.71
 ;;^UTILITY(U,$J,358.3,27888,1,5,0)
 ;;=5^Loss Of Libido
 ;;^UTILITY(U,$J,358.3,27888,2)
 ;;=^1
 ;;^UTILITY(U,$J,358.3,27889,0)
 ;;=596.54^^162^1789^35
 ;;^UTILITY(U,$J,358.3,27889,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27889,1,4,0)
 ;;=4^596.54
 ;;^UTILITY(U,$J,358.3,27889,1,5,0)
 ;;=5^Neurogenic Bladder 
 ;;^UTILITY(U,$J,358.3,27889,2)
 ;;=^304798
 ;;^UTILITY(U,$J,358.3,27890,0)
 ;;=788.43^^162^1789^36
 ;;^UTILITY(U,$J,358.3,27890,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27890,1,4,0)
 ;;=4^788.43
 ;;^UTILITY(U,$J,358.3,27890,1,5,0)
 ;;=5^Nocturia
 ;;^UTILITY(U,$J,358.3,27890,2)
 ;;=^84740
 ;;^UTILITY(U,$J,358.3,27891,0)
 ;;=605.^^162^1789^39
 ;;^UTILITY(U,$J,358.3,27891,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27891,1,4,0)
 ;;=4^605.
 ;;^UTILITY(U,$J,358.3,27891,1,5,0)
 ;;=5^Phimosis
 ;;^UTILITY(U,$J,358.3,27891,2)
 ;;=^104159
 ;;^UTILITY(U,$J,358.3,27892,0)
 ;;=601.0^^162^1789^41
 ;;^UTILITY(U,$J,358.3,27892,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27892,1,4,0)
 ;;=4^601.0
 ;;^UTILITY(U,$J,358.3,27892,1,5,0)
 ;;=5^Prostatitis, Acute
 ;;^UTILITY(U,$J,358.3,27892,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,27893,0)
 ;;=590.10^^162^1789^43
 ;;^UTILITY(U,$J,358.3,27893,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27893,1,4,0)
 ;;=4^590.10
 ;;^UTILITY(U,$J,358.3,27893,1,5,0)
 ;;=5^Pyelonephritis, Acute
 ;;^UTILITY(U,$J,358.3,27893,2)
 ;;=^270369
 ;;^UTILITY(U,$J,358.3,27894,0)
 ;;=590.00^^162^1789^44
 ;;^UTILITY(U,$J,358.3,27894,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27894,1,4,0)
 ;;=4^590.00
 ;;^UTILITY(U,$J,358.3,27894,1,5,0)
 ;;=5^Pyelonephritis, Chronic
 ;;^UTILITY(U,$J,358.3,27894,2)
 ;;=^270367
 ;;^UTILITY(U,$J,358.3,27895,0)
 ;;=788.7^^162^1789^53
 ;;^UTILITY(U,$J,358.3,27895,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27895,1,4,0)
 ;;=4^788.7
 ;;^UTILITY(U,$J,358.3,27895,1,5,0)
 ;;=5^Urethral Discharge
 ;;^UTILITY(U,$J,358.3,27895,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,27896,0)
 ;;=131.02^^162^1789^56
 ;;^UTILITY(U,$J,358.3,27896,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27896,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,27896,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,27896,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,27897,0)
 ;;=597.80^^162^1789^54
 ;;^UTILITY(U,$J,358.3,27897,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27897,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,27897,1,5,0)
 ;;=5^Urethritis NOS
 ;;
 ;;$END ROU IBDEI1KM
